Literature DB >> 28783146

Mesenchymal stromal cells for steroid-refractory acute GvHD.

C Fernández-Maqueda1, R Gonzalo-Daganzo1, C Regidor1, T Martín-Donaire1, R Sánchez1, J L Bueno1, G Bautista1, A De Liglesia1, Y Gutiérrez1, M García-Berciano1, R Forés1, A Royuela2, M N Fernández1, R F Duarte1, J R Cabrera-Marín1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28783146     DOI： 10.1038/bmt.2017.177

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).

Authors:  Igor B Resnick; Claudine Barkats; Michael Y Shapira; Polina Stepensky; Allan I Bloom; Avichai Shimoni; David Mankuta; Nira Varda-Bloom; Lyudmila Rheingold; Moshe Yeshurun; Bella Bielorai; Amos Toren; Tsila Zuckerman; Arnon Nagler; Reuven Or
Journal:  Am J Blood Res       Date:  2013-08-19

2.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

3.  Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.

Authors:  Fermín Sánchez-Guijo; Teresa Caballero-Velázquez; Olga López-Villar; Alba Redondo; Rocío Parody; Carmen Martínez; Eduardo Olavarría; Enrique Andreu; Felipe Prósper; María Díez-Campelo; Carmen Regidor; Eva Villaron; Lucía López-Corral; Dolores Caballero; María-Consuelo Del Cañizo; José Antonio Pérez-Simon
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-19       Impact factor: 5.742

Review 4.  Ex vivo expansion of mesenchymal stromal cells.

Authors:  Maria Ester Bernardo; Angela Maria Cometa; Daria Pagliara; Luciana Vinti; Francesca Rossi; Rosaria Cristantielli; Giuseppe Palumbo; Franco Locatelli
Journal:  Best Pract Res Clin Haematol       Date:  2011-02-23       Impact factor: 3.020

5.  Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation.

Authors:  Maria Ester Bernardo; Franco Locatelli
Journal:  Methods Mol Biol       Date:  2016

6.  Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.

Authors:  Martino Introna; Giovanna Lucchini; Erica Dander; Stefania Galimberti; Attilio Rovelli; Adriana Balduzzi; Daniela Longoni; Fabio Pavan; Francesca Masciocchi; Alessandra Algarotti; Caterina Micò; Anna Grassi; Sara Deola; Irene Cavattoni; Giuseppe Gaipa; Daniela Belotti; Paolo Perseghin; Matteo Parma; Enrico Pogliani; Josee Golay; Olga Pedrini; Chiara Capelli; Sergio Cortelazzo; Giovanna D'Amico; Andrea Biondi; Alessandro Rambaldi; Ettore Biagi
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-07       Impact factor: 5.742

7.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

8.  Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.

Authors:  Ke Zhao; Rui Lou; Fen Huang; Yanwen Peng; Zujun Jiang; Ke Huang; Xiuli Wu; Yu Zhang; Zhiping Fan; Hongsheng Zhou; Can Liu; Yang Xiao; Jing Sun; Yangqiu Li; Peng Xiang; Qifa Liu
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-06       Impact factor: 5.742

9.  Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.

Authors:  Rosa Gonzalo-Daganzo; Carmen Regidor; Trinidad Martín-Donaire; Miguel Angel Rico; Guiomar Bautista; Isabel Krsnik; Rafael Forés; Emilio Ojeda; Isabel Sanjuán; Jose A García-Marco; Belen Navarro; Santiago Gil; Rocio Sánchez; Nuria Panadero; Yolanda Gutiérrez; Miguel García-Berciano; Nuria Pérez; Isabel Millán; Rafael Cabrera; Manuel N Fernández
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

10.  GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC.

Authors:  Natalie Fekete; Markus T Rojewski; Daniel Fürst; Ludwika Kreja; Anita Ignatius; Julia Dausend; Hubert Schrezenmeier
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240
View more
  2 in total

Review 1.  Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers.

Authors:  Tik Shing Cheung; Giuliana Minani Bertolino; Chiara Giacomini; Martin Bornhäuser; Francesco Dazzi; Antonio Galleu
Journal:  Front Immunol       Date:  2020-06-25       Impact factor: 7.561

2.  Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.

Authors:  Ran Wu; Chuanxu Liu; Xiaohui Deng; Linjun Chen; Siguo Hao; Liyuan Ma
Journal:  J Cell Mol Med       Date:  2019-11-28       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.